Item 8.01 Other Events.

On January 9, 2023, Tengjun Biotechnology Corp. (the "Company") conducted its initial closing of the public offering of its common stock (the "Initial Closing") pursuant to the Company's registration statement on Form S-1 (File No. 333-266300) initially filed with the Securities and Exchange Commission ("Commission") on July 22, 2022 and declared effective on November 4, 2022 (the "Registration Statement"), whereby the Company offered and sold 3,000,000 shares of common stock (the "Shares") at $1.00 per share for a total purchase price of $3,000,000 (the "Initial Closing Amount") from the investors. The Initial Closing Amount equals to the minimum offering amount as set forth in the Registration Statement. The Company may conduct additional closings of this public offering from time to time in the future within the timeframe as described in the Registration Statement.


                                       1

© Edgar Online, source Glimpses